LCN2 and nasopharyngeal carcinoma: Conversely, a recent study showed that a high expression of LCN2 is associated with a poor 5-year relapse-free survival and local relapse-free survival, but not with distant metastasis-free survival, progression-free survival and overall survival between high- and low-LCN2-expression groups in NPC patients [9].